Log in

NYSEARCA:IBDQiBonds Dec 2025 Term Corporate ETF Stock Price, Forecast & News

$26.58
+0.06 (+0.23 %)
(As of 05/29/2020 04:00 PM ET)
Add
Today's Range
$26.48
Now: $26.58
$27.04
50-Day Range
$25.34
MA: $26.05
$26.58
52-Week Range
$22.50
Now: $26.58
$27.04
Volume1.47 million shs
Average Volume194,519 shs
Market Capitalization$598.05 million
P/E RatioN/A
Dividend Yield3.02%
BetaN/A

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.91 out of 5 stars


Basic Details

Issuer iShares
Fund NameiBonds Dec 2025 Term Corporate ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:IBDQ
Inception Date3/11/2015
Fund ManagerJames Mauro, Scott Radell
WebN/A
PhoneN/A

Fund Focus

Asset ClassFixed Income
BenchmarkBloomberg Barclays December 2025 Maturity Corporate Index
CategoryCorporate
FocusInvestment Grade
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$594.54 million
Average Daily Volume$185,625.40
Discount/Premium0.16%

ETF Expenses

Management Fee0.10%
Other Expenses0.00%
Total Expenses0.10%
Fee Waiver0.00%
Net Expenses0.10%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerVirtu Financial

Receive IBDQ News and Ratings via Email

Sign-up to receive the latest news and ratings for IBDQ and its competitors with MarketBeat's FREE daily newsletter.

Geographic Exposure of iBonds Dec 2025 Term Corporate ETF (NYSEARCA:IBDQ)
Currency Exposure of iBonds Dec 2025 Term Corporate ETF (NYSEARCA:IBDQ)
Sector Exposure of iBonds Dec 2025 Term Corporate ETF (NYSEARCA:IBDQ)
Industry Exposure of iBonds Dec 2025 Term Corporate ETF (NYSEARCA:IBDQ)

iBonds Dec 2025 Term Corporate ETF (NYSEARCA:IBDQ) Frequently Asked Questions

How has iBonds Dec 2025 Term Corporate ETF's stock been impacted by COVID-19 (Coronavirus)?

iBonds Dec 2025 Term Corporate ETF's stock was trading at $25.48 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, IBDQ shares have increased by 4.3% and is now trading at $26.58. View which stocks have been most impacted by Coronavirus.

How often does iBonds Dec 2025 Term Corporate ETF pay dividends? What is the dividend yield for iBonds Dec 2025 Term Corporate ETF?

iBonds Dec 2025 Term Corporate ETF announced a monthly dividend on Monday, February 3rd. Investors of record on Tuesday, February 4th will be given a dividend of $0.0617 per share on Friday, February 7th. This represents a $0.74 annualized dividend and a yield of 2.79%. The ex-dividend date is Monday, February 3rd. View iBonds Dec 2025 Term Corporate ETF's dividend history.

Has iBonds Dec 2025 Term Corporate ETF been receiving favorable news coverage?

News stories about IBDQ stock have been trending extremely negative this week, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. iBonds Dec 2025 Term Corporate ETF earned a news impact score of -5.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutiBonds Dec 2025 Term Corporate ETF.

What other stocks do shareholders of iBonds Dec 2025 Term Corporate ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iBonds Dec 2025 Term Corporate ETF investors own include CenterPoint Energy (CNP), Chevron (CVX), EAGLE POINT CR/COM (ECC), Ford Motor (F), SPDR S&P Global Natural Resources ETF (GNR), iShares Core S&P Mid-Cap ETF (IJH), JPMorgan Chase & Co. (JPM), Kinder Morgan (KMI), L Brands (LB) and Lockheed Martin (LMT).

What is iBonds Dec 2025 Term Corporate ETF's stock symbol?

iBonds Dec 2025 Term Corporate ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "IBDQ."

Who are iBonds Dec 2025 Term Corporate ETF's major shareholders?

iBonds Dec 2025 Term Corporate ETF's stock is owned by a variety of retail and institutional investors. Top institutional investors include Capital Investment Advisors LLC (4.94%), Motley Fool Wealth Management LLC (4.15%), Trust Co of Kansas (1.85%), US Bancorp DE (0.93%), United Capital Financial Advisers LLC (0.64%) and Sandy Spring Bank (0.56%).

Which institutional investors are selling iBonds Dec 2025 Term Corporate ETF stock?

IBDQ stock was sold by a variety of institutional investors in the last quarter, including Motley Fool Wealth Management LLC, United Capital Financial Advisers LLC, Exchange Capital Management Inc., and Bank of New York Mellon Corp.

Which institutional investors are buying iBonds Dec 2025 Term Corporate ETF stock?

IBDQ stock was purchased by a variety of institutional investors in the last quarter, including Trust Co of Kansas, Sandy Spring Bank, Janney Montgomery Scott LLC, US Bancorp DE, Bainco International Investors, Archford Capital Strategies LLC, Capital Investment Advisors LLC, and First National Bank of South Miami.

How do I buy shares of iBonds Dec 2025 Term Corporate ETF?

Shares of IBDQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is iBonds Dec 2025 Term Corporate ETF's stock price today?

One share of IBDQ stock can currently be purchased for approximately $26.58.

How big of a company is iBonds Dec 2025 Term Corporate ETF?

iBonds Dec 2025 Term Corporate ETF has a market capitalization of $598.05 million.

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.